Innovative probiotics developed for a wide range of indications

Gut microbiota impacts lipid metabolism

Gut bacteria have an impact on several molecules linked to lipid metabolism, including bile salts1,2. Plus, an altered microbiota diversity has been associated with hyperlipidemia-related diseases and obesity3,4.

AB-LIFE™

L. plantarum KABP™ 011 (CECT 7527)
L. plantarum KABP™ 012 (CECT 7528)
L. plantarum KABP™ 013 (CECT 7529)

AB-LIFE™ reduces cholesterol and triglyceride blood levels, as the ideal complement of a healthy lifestyle

Additional compounds:

Vitamin B1, Omega 3 (alpha linolenic acid)
document

LipiGO®

Saccharomyces cerevisiae extract

LipiGO® ensures a successful and safe weight loss and maintains the ideal body weight without risks of rebound.

Want to know more about our products?

What our partners say

Want to know more about our products?

References

1. Tang, W. H. W., Kitai, T. & Hazen, S. L. Gut microbiota in cardiovascular health and disease. Circulation Research vol. 120 1183–1196 (2017). 2. Herrema, H, Nieuwdorp, M. & Groen, A. K. Microbiome and Cardiovascular Disease. Handb Exp Pharmacol (2020).  3. Karlsson, F. H. et al. Symptomatic atherosclerosis is associated with an altered gut metagenome. Nat. Commun. 3, (2012). 4. Ley, R. E., Turnbaugh, P. J., Klein, S. & Gordon, J. I. Microbial ecology: Human gut microbes associated with obesity. Nature 444, 1022–1023 (2006).